Employees: Second Sight employs a team of over 70 employees dedicated to the success of the company and its mission. The team is comprised of exceptional R&D, manufacturing, and logistics personnel as well as seasoned regulatory, clinical and quality experts.

Directors: Second Sight's executive board consists of six members who are veterans of the active implantable medical device and ophthalmic device sectors. These include:

Alfred E. Mann, Chairman

William Link, board member

Aaron Mendelsohn, board member

Gregg Williams, board member

Robert Greenberg, MD, PhD, President and CEO

Thomas Fogarty, board member

Collaborators: Second Sight collaborates with a variety of institutional research partners including:

Advanced Bionics Corp./Boston Scientific
Alfred E. Mann Foundation
California Institute of Technology
Doheny Eye Institute
North Carolina State University
Salk Institute
University of Southern California
UC Santa Cruz

DOE National laboratories
-Argonne National Lab
-Brookhaven National Lab
-Lawrence Livermore National Lab
-Los Alamos National Lab
-Oak Ridge National Lab
-Sandia National Lab

Additionally, Second Sight receives significant financial support from the National Eye Institute of the National Institutes of Health.